Comparison

CEF2, Influenza Virus PA (46-54)

Item no. AS-28311
Manufacturer AnaSpec
Amount 1 mg
Category
Type Peptides
Format Lyophilized
Specific against other
Conjugate/Tag Unconjugated
Purity Peak Area by HPLC ≥95%
Sequence H-Phe-Met-Tyr-Ser-Asp-Phe-His-Phe-Ile-OH
Citations Ref: Gianfrani C. et al. Human Immunol. 61, 438 (2000); Macken, C. et al. "The value of a database in surveillance and vaccine selection." in Options for the Control of Influenza IV. A.D.M.E. Osterhaus, N. Cox & A.W. Hampson (Eds.) Amsterdam: Elsevier Science, 103 (2001). Berkhoff, E. et al. J. Virol. 78: 5216 (2004).
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias FMYSDFHFI
Shipping Condition Room temperature
Available
Manufacturer - Category
Catalog Peptides / Catalog Peptides Gr / Peptides
Manufacturer - Targets
Influenza Virus
Shipping Temperature
RT
Storage Conditions
- 20 °C
Molecular Weight
1206.4
Manufacturer - Research Area
Immunology and Infectious disease / Virology
Description
HLA-A*0201 restricted epitope from influenza virus RNA polymerase subunit, PA (46-54).
Sequence One-Letter Code
FMYSDFHFI
Post Synthesis Coupling
No
Usage
Research use
UNSPSC
12352202
GTIN
5400535023867

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Delivery expected until 1/22/2026 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close